Table 4 Cone bioassay results using An. coluzzii (strain sensitive) per semester and types of LLINs
Net type | Semesters KD60 (n = samples analyzed) [95% CI] | |||||
|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | |
Dawa Plus® 2.0 | 96.4 (n = 30) [82.7–99] | 96.6 (n = 30) [82.7–99] | 100 (n = 30) [88.4–100 | 96.6 (n = 30) [82.7–99] | 100 (n = 29) [88–100] | 95.2 (n = 21) [76.2–99] |
NetProtect® | 100 (n = 30) [88.4–100] | 96.6 (n = 30) [82.7–99] | 100 (n = 30) [88.4–100] | 100 (n = 30) [88.4–100] | 93.3 (n = 15) [77.9–99] | 95.2 (n = 21) [76–99.8] |
Life Net® | 100 (n = 30) [88.4–100] | 100 (n = 30) [88.4–100] | 100 (n = 29) [88–100] | 100 (n = 29) [88–100] | 100 (n = 30) [78–100] | 100 (n = 10) [69–100] |
Olyset Net ® | 100 (n = 30) [88.4–100] | 96.6 (n = 30) [82.7–99] | 100 (n = 28) [88.4–100] | 100 (n = 30) [88.4–100] | 93.3 (n = 30) [77.9 -99.1] | 95.2 (n = 30) [76–99.8] |
PermaNet® 2.0 | 100 (n = 30) [88.4–100] | 96.6 (n = 28) [82.7–99] | 100 (n = 30) [88.4–100] | 100 (n = 30) [88.4–100] | 93 (n = 29) [77.9–99,1] | 95 (n = 30) [76.1–99.8] |
Mortality rate 95% CI | ||||||
Dawa Plus® 2.0 | 100 [88.4–100] | 93.3 [78- 99] | 96.6 [83–99] | 93.3 [78–99] | 51.7 [33–71] | 100 [84–100] |
NetProtect® | 66.7 [47–82] | 93.3 [78–99] | 93.3 [78–99] | 86.7 [69–96] | 56.6 [37–74] | 80 [58–94] |
Life Net® | 100 [88–100] | 100 [88–100] | 100 [88–100] | 100 [88–100] | 100 [78–100] | 100 [69–100] |
Olyset Net ® | 96.6 [83–99] | 20 [7_38] | 28 [13–49] | 13 [4–30] | 46 [28–65] | 33.3 [17–52] |
PermaNet® 2.0 | 96.6 [83–99] | 82 [63–93] | 100 [88–100] | 100 [88–100] | 93 [77–99] | 83 [65–94] |